Literature DB >> 16985904

Management of stress urinary incontinence.

Jeffrey L Cornella.   

Abstract

Although there is renewed interest in conservative therapies for stress urinary incontinence, such as pelvic floor exercises, electrical stimulation, and duloxetine therapy, surgery remains the primary choice in managing this condition. Surgical options include paravaginal defect repair, the Marshall-Marchetti-Krantz procedure, open and laparoscopic Burch urethropexy, and pubovaginal sling procedures. There is a growing trend in the United States toward use of the pubovaginal sling procedure as the primary operation for urinary incontinence due to less invasive techniques. Studies comparing the pubovaginal sling with open urethropexy have shown similar short-term cure rates. More large prospective, randomized studies are needed to assess long-term rates.

Entities:  

Year:  2004        PMID: 16985904      PMCID: PMC1472874     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  40 in total

1.  Laparoscopic versus open Burch retropubic urethropexy: comparison of morbidity and costs when performed with concurrent vaginal prolapse repairs.

Authors:  Andrew J Walter; Abraham N Morse; Robert A Hammer; Joseph G Hentz; Javier F Magrina; Jeffrey L Cornella; Paul M Magtibay
Journal:  Am J Obstet Gynecol       Date:  2002-04       Impact factor: 8.661

2.  A randomized comparison of Burch colposuspension and abdominal paravaginal defect repair for female stress urinary incontinence.

Authors:  M Colombo; R Milani; D Vitobello; A Maggioni
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

3.  Laparoscopic bladderneck suspension.

Authors:  T G Vancaillie; W Schuessler
Journal:  J Laparoendosc Surg       Date:  1991-06

4.  Burch colposuspension: a 10-20 year follow up.

Authors:  M Alcalay; A Monga; S L Stanton
Journal:  Br J Obstet Gynaecol       Date:  1995-09

5.  Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence.

Authors:  C G Nilsson; N Kuuva; C Falconer; M Rezapour; U Ulmsten
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

6.  Change in urethral pressure during voluntary pelvic floor muscle contraction and vaginal electrical stimulation.

Authors:  K Bø; T Talseth
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

7.  Burch colposuspension versus modified Marshall-Marchetti-Krantz urethropexy for primary genuine stress urinary incontinence: a prospective, randomized clinical trial.

Authors:  M Colombo; S Scalambrino; A Maggioni; R Milani
Journal:  Am J Obstet Gynecol       Date:  1994-12       Impact factor: 8.661

8.  Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Continence Program for Women Research Group.

Authors:  J F Wyman; J A Fantl; D K McClish; R C Bump
Journal:  Am J Obstet Gynecol       Date:  1998-10       Impact factor: 8.661

9.  Dynamic urethral pressure profilometry pressure transmission ratio: what do the numbers really mean?

Authors:  B A Rosenzweig; N N Bhatia; A L Nelson
Journal:  Obstet Gynecol       Date:  1991-04       Impact factor: 7.661

10.  Surgical results and urodynamic studies 10 years after retropubic colpourethrocystopexy.

Authors:  G Herbertsson; C S Iosif
Journal:  Acta Obstet Gynecol Scand       Date:  1993-05       Impact factor: 3.636

View more
  3 in total

Review 1.  Pubovaginal sling materials and their outcomes.

Authors:  Ömer Bayrak; David Osborn; William Stuart Reynolds; Roger Roman Dmochowski
Journal:  Turk J Urol       Date:  2014-12

2.  Pleated colposuspension: Our modification of Burch colposuspension.

Authors:  Vesna S Antovska
Journal:  Indian J Urol       Date:  2013-07

3.  Prevalence, Risk Factors, Quality of Life, and Health-Care Seeking Behaviors of Female Urinary Incontinence: Results From the 4th Korean National Health and Nutrition Examination Survey VI (2007-2009).

Authors:  Choon Sig Kwon; Jun Ho Lee
Journal:  Int Neurourol J       Date:  2014-03-31       Impact factor: 2.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.